Thomas J Borody (Thomas Borody)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Irritable Bowel Syndrome

Angiotensin Converting Enzyme

Helicobacter Pylori

Top Venues

Nature communications

Antibiotics (Basel, Switzerland)

Future microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
Laurence Don Wai Luu, Abhimanu Pandey, Sudarshan Paramsothy, Chinh Ngo, Natalia Castaño-Rodríguez, Cheng Liu, Michael A Kamm, Thomas J Borody, Si Ming Man, Nadeem O Kaakoush
Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice. Nature communications 15 (1) (2024)
Marwan E Majzoub, Laurence D W Luu, Craig Haifer, Sudarshan Paramsothy, Thomas J Borody, Rupert W Leong, Torsten Thomas, Nadeem O Kaakoush
Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling. mSystems (2024)
David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
David Yates Graham, Saleh A Naser, Thomas J Borody, Zbigniew Hebzda, Harry Sarles, Scott Levenson, Robert Hardi, Tomasz Arłukowicz, Petar Svorcan, Reza Fathi, Aida Bibliowicz, Patricia Anderson, Patrick McLean, Clara Fehrmann, M Scott Harris, Shuhong Zhao, Ira N Kalfus
Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease. Antibiotics (Basel, Switzerland) 13 (8) (2024)
David E Scheim, Peter I Parry, David J Rabbolini, Colleen Aldous, Morimasa Yagisawa, Robert Clancy, Thomas J Borody, Wendy E Hoy
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses. Viruses 16 (4) (2024)
David Yates Graham, Saleh A Naser, Thomas J Borody, Zbigniew Hebzda, Harry Sarles, Scott Levenson, Robert Hardi, Tomasz Arłukowicz, Petar Svorcan, Reza Fathi, Aida Bibliowicz, Patricia Anderson, Patrick McLean, Clara Fehrmann, M Scott Harris, Shuhong Zhao, Ira N Kalfus
Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease. Antibiotics (Basel, Switzerland) 13 (8) (2024)
Laurence Don Wai Luu, Abhimanu Pandey, Sudarshan Paramsothy, Chinh Ngo, Natalia Castaño-Rodríguez, Cheng Liu, Michael A Kamm, Thomas J Borody, Si Ming Man, Nadeem O Kaakoush
Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice. Nature communications 15 (1) (2024)
Laurence Don Wai Luu, Abhimanu Pandey, Sudarshan Paramsothy, Chinh Ngo, Natalia Castaño-Rodríguez, Cheng Liu, Michael A Kamm, Thomas J Borody, Si Ming Man, Nadeem O Kaakoush
Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice. Nature communications 15 (1) (2024)
Sabine Hazan, Sonya Dave, Anoja W Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A McCullough, Thomas J Borody
Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients. Future microbiology 17 (2022)
Sabine Hazan, Sonya Dave, Thomas J Borody, Peter A McCullough
Letter in reply: more power to ivermectin multidrug therapy. Future microbiology 17 (2022)
Thomas Sebastian Benedikt Schmidt, Simone S Li, Oleksandr M Maistrenko, Wasiu A Akanni, Luis Pedro Coelho, Sibasish Dolai, Anthony Fullam, Anna M Glazek, Rajna Hercog, Hilde Herrema, Ferris Jung, Stefanie Kandels, Askarbek Orakov, Roman Thielemann, Moritz von Stetten, Thea Van Rossum, Vladimir Benes, Thomas J Borody, Willem Meindert de Vos, Cyriel Y Ponsioen, Max Nieuwdorp, Peer Bork
Drivers and determinants of strain dynamics following fecal microbiota transplantation. Nature medicine 28 (9) (2022)
Harrison Hamblin, Anoja W Gunaratne, Annabel K Clancy, Denise Pilarinos, Antoinette LeBusque, Marie Vic M Dawson, Thomas J Borody
Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience. Gastroenterology research and practice 2022 (2022)
Craig Haifer, Sudarshan Paramsothy, Thomas J Borody, Annabel Clancy, Rupert W Leong, Nadeem O Kaakoush
Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection. mSystems 6 (1) (2021)
Anoja W Gunaratne, Harrison Hamblin, Annabel Clancy, Aleja Jane Marie C Magat, Marie Vic M Dawson, Jeffrey Tu, Thomas J Borody
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study. Helicobacter 26 (5) (2021)
Matthew Z DeMaere, Michael Y Z Liu, Enmoore Lin, Steven Philip Djordjevic, Ian G Charles, Paul Worden, Catherine M Burke, Leigh G Monahan, Melissa Gardiner, Thomas J Borody, Aaron E Darling
Metagenomic Hi-C of a Healthy Human Fecal Microbiome Transplant Donor. Microbiology resource announcements 9 (6) (2020)
Craig Haifer, Colleen R Kelly, Sudarshan Paramsothy, David Andresen, Lito E Papanicolas, Genevieve L McKew, Thomas J Borody, Michael Kamm, Samuel Paul Costello, Jane M Andrews, Jacob Begun, Hiu Tat Chan, Susan J Connor, Simon Ghaly, Paul Dr Johnson, Daniel A Lemberg, Ramesh Paramsothy, Andrew M Redmond, Harsha Sheorey, David van der Poorten, Rupert W L Leong
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut 69 (5) (2020)
Graham J Britton, Eduardo J Contijoch, Matthew P Spindler, Varun Aggarwala, Belgin Dogan, Gerold Bongers, Lani San Mateo, Andrew Baltus, Anuk Das, Dirk Gevers, Thomas J Borody, Nadeem O Kaakoush, Michael A Kamm, Hazel Mitchell, Sudarshan Paramsothy, Jose C Clemente, Jean Frederic Colombel, Kenneth W Simpson, Marla C Dubinsky, Ari M Grinspan, Jeremiah J Faith
Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas. Proceedings of the National Academy of Sciences of the United States of America 117 (35) (2020)